Search

everythinglearnresearchcommunity

for

Search:↓

Combining dutasteride mesotherapy with oral minoxidil is more effective for hair loss than using oral minoxidil alone.

Canagliflozin helps overcome progestin resistance in certain endometrial cancer cells.

Steroid Sulfatase inhibitors show promise in treating hormone-dependent disorders like cancers, hair loss, and acne, with 667COUMATE being a potential candidate for breast cancer treatment trials.

The effect of GLP-1 RAs on erectile function is unclear and needs more research.

Targeting neurosteroids may help prevent drug relapse.

Some newly made compounds are promising for treating enlarged prostate, hair loss, viruses, and prostate cancer, and might be better than current drugs.

These drugs raise prostaglandin-like material in dog blood, possibly causing blood vessel widening.

Dutasteride is more cost-effective than finasteride for treating benign prostatic hyperplasia in Montenegro.

Compounds 4, 4b, and 4c effectively inhibit an enzyme linked to testosterone conversion without significant toxicity.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

Bimatoprost shows promise for treating vitiligo, especially when combined with other therapies.

Progesterone protects brain cells, but Provera does not.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

Chlormadinone acetate is a strong, well-tolerated hormone used in birth control and hormone therapy with benefits for menstrual pain and skin conditions.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

Certain drugs can reduce bladder muscle contractions, potentially helping treat bladder diseases.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

AMP-303 injections can increase hair growth in androgenetic alopecia with minimal side effects.

Blocking progesterone metabolism can cause depression-like behavior in mice.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

Agmatine may help reduce seizures linked to hormone changes in female rats.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

Current treatments for lower urinary tract symptoms include α1-blockers, 5ARIs, PDE5 inhibitors, anticholinergic agents, and β3-adrenergic receptor agonists.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Certain compounds reduced hamster flank organ size by inhibiting 5α-reductase, like finasteride, without affecting androgen receptors.

Prostaglandins may contribute to male hair loss; targeting them could help treat it.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

Reducing 5α-reductase activity helps endometrial cells differentiate, aiding pregnancy.

Different halogens on progesterone derivatives can either block or mimic male hormone effects, depending on their type and amount.